Investigator Sponsored Studies, grants and sponsorships
Vertex Pharmaceuticals offers grants for independent research and innovation focused on cystic fibrosis and other serious diseases, supporting studies that advance scientific knowledge and patient care.
Funder: Vertex Pharmaceuticals
Due Dates: Rolling (most programs) | 2026 (next cycle for Circle of Care, RIA, and VIA awards)
Funding Amounts: No set cap for general grants/sponsorships; CF Independent Research Innovation Awards: $750,000 over 3 years; Mentored RIA: up to $125,000 over 2 years; VIA: up to $750,000 per project.
Summary: Supports independent research, education, advocacy, and sponsorships in cystic fibrosis and other serious diseases, with rolling submissions and targeted competitive cycles.
Key Information: Most requests must be submitted at least 45–60 days before event/start; funding generally cannot exceed 30% of an organization's annual budget.
Description
Vertex Pharmaceuticals provides a range of grant and sponsorship opportunities to support independent scientific research, medical education, patient advocacy, and community initiatives. The focus is on advancing knowledge and care for people living with cystic fibrosis (CF) and other serious diseases such as sickle cell disease, beta thalassemia, IgA nephropathy, pain, type 1 diabetes, and rare diseases. Funding is available for investigator-sponsored studies (ISS), educational programs, patient/caregiver initiatives, and organizational sponsorships, with specific competitive cycles for certain CF research awards.
